Literature DB >> 3584420

Impact of prolonged incubation on disk diffusion susceptibility test results for Staphylococcus aureus.

M E Mulligan, D M Citron, R Y Kwok, J P Wheelock, F K Farrohi, J A Hindler, L Johnston.   

Abstract

Because strains of Staphylococcus aureus that are resistant to penicillinase-resistant penicillins may be difficult to detect in the clinical laboratory, a variety of changes in methodology have been suggested to increase their detection. In 1984, the West Los Angeles Veterans Administration Medical Center experienced an increase in clinically significant strains of oxacillin-resistant S. aureus. To insure that such strains would not be missed by the disk diffusion test methods employed for routine testing, changes in methodology were insituted. These included interpreting zone diameters around oxacillin disks at 48 h of incubation. We collected 139 isolates from patients thought to have oxacillin-resistant S. aureus based on these test results and later retested the isolates using microdilution MIC testing. Only 85 isolates (61%) had microdilution oxacillin MICs of greater than or equal to 8.0 micrograms/ml, whereas 54 (39%) had oxacillin MICs of less than or equal to 2.0 micrograms/ml. A review of medical records revealed that in 1 year there were 98 patients with isolates appearing resistant by disk diffusion but not confirmed by microdilution MICs; many patients were placed in isolation and treated with specific antimicrobial agents. We conclude that incubation of oxacillin disk diffusion tests for longer than 24 h in conjunction with disregard for resistance to other classes of antimicrobial agents may result in an unacceptably high degree of false resistance results. Because the resistance of S. aureus has important therapeutic and infection control implications, it is necessary to recognize problems that may result in ambiguous or inaccurate susceptibility results.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584420      PMCID: PMC266100          DOI: 10.1128/jcm.25.5.840-844.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

2.  Variation in the abilities of automated, commercial, and reference methods to detect methicillin-resistant (heteroresistant) Staphylococcus aureus.

Authors:  S L Hansen; P K Freedy
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

3.  New recommendations for disk diffusion antimicrobial susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.

Authors:  L K McDougal; C Thornsberry
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

4.  The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins.

Authors:  L K McDougal; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

5.  Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain.

Authors:  J E Peacock; D R Moorman; R P Wenzel; G L Mandell
Journal:  J Infect Dis       Date:  1981-12       Impact factor: 5.226

6.  The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit.

Authors:  R W Haley; A W Hightower; R F Khabbaz; C Thornsberry; W J Martone; J R Allen; J M Hughes
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

7.  Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.

Authors:  C Thornsberry; L K McDougal
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

8.  Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus.

Authors:  L D Sabath
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

9.  Unusual susceptibility of methicillin-resistant Staphylococcus aureus to erythromycin, clindamycin, gentamicin, and tetracycline at 30 degrees C but not at 35 degrees C.

Authors:  W D Welch; P M Southern
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

10.  Effect of the source of Mueller-Hinton agar and resistance frequency on the detection of methicillin-resistant Staphylococcus aureus.

Authors:  J A Hindler; C B Inderlied
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

  10 in total
  5 in total

1.  Detection of borderline oxacillin-resistant Staphylococcus aureus and differentiation from methicillin-resistant strains.

Authors:  H Liu; G Buescher; N Lewis; S Snyder; D Jungkind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

2.  Compositionally graded doped hydroxyapatite coating on titanium using laser and plasma spray deposition for bone implants.

Authors:  Dongxu Ke; Ashley A Vu; Amit Bandyopadhyay; Susmita Bose
Journal:  Acta Biomater       Date:  2018-11-27       Impact factor: 8.947

3.  Comparison of screening methods to identify methicillin-resistant Staphylococcus aureus.

Authors:  G Kampf; K Weist; S Swidsinski; M Kegel; H Rüden
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

4.  Spurious oxacillin resistance in Staphylococcus aureus because of defective oxacillin disks.

Authors:  J M Boyce; J R Lonks; A A Medeiros; E F Papa; S Campbell
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

5.  Use of the National Committee for Clinical Laboratory Standards guidelines for disk diffusion susceptibility testing in New York state laboratories.

Authors:  J A Kiehlbauch; G E Hannett; M Salfinger; W Archinal; C Monserrat; C Carlyn
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.